Tokyo, Nov. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063518) titled 'A study on the effects of a virtual reality (VR) emergency life-saving train... Read More
Tokyo, Nov. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063510) titled 'A prospective observational study to investigate the effects of pemafinrate ... Read More
Tokyo, Nov. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063487) titled 'Interventions to Improve Food Environments and Their Reported Outcomes Among... Read More
Tokyo, Nov. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061897) titled 'A Study of the Relationship Between the Timing of Mobilization and Safety an... Read More
Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A rapid assessment and treatment pathway using targeted therapy and ... Read More
Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Social prescribing program for adults receiving dialysis’. The follo... Read More
Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Better matching care to the needs of patients with musculoskeletal p... Read More
Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘Pain relief in patients undergoing skin graft surgery using a local ... Read More
Australia, Nov. 4 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘The Dance for Me Study: Testing a Dance Exercise Program for People ... Read More
Singapore, Nov. 4 -- The Health Sciences Authority received information related to the study titled 'A Phase II, Open-label Platform Study of Osimertinib in Combination with Anti-cancer Agents in Part... Read More